Market revenue in 2023 | USD 49,757.1 million |
Market revenue in 2030 | USD 77,813.9 million |
Growth rate | 6.6% (CAGR from 2023 to 2030) |
Largest segment | Lipid panel tests |
Fastest growing segment | HGB/HCT tests |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Liver panel tests, Renal panel tests, Lipid panel tests |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Labcorp Holdings Inc, ARUP Laboratories, OPKO Health Inc, Clinical Reference Laboratory, Sonic Healthcare Ltd, Cinven, Unilabs |
Lipid panel tests was the largest segment with a revenue share of 12.46% in 2023. Horizon Databook has segmented the U.S. clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is the biggest and most developed market for clinical laboratory tests. The market in the U.S. is very extensive and accessible to almost the whole country's population. For instance, over 13 billion tests were performed annually before the pandemic, while there are over 200,000 CLIA-certified laboratories in the country.
The nation's high burden of chronic illnesses requires support from clinical laboratory tests for efficient patient care and treatment. For instance, in 2022, the National Association of Chronic Disease Directors stated that nearly 60% of people in the country suffer from a chronic disease. Thus, the management and monitoring of these tests require support from clinical laboratory tests for decision-making.
The availability of the ELF Test at national reference laboratories brings immediate wide-ranging access to clinicians and patients in the country, providing the best chance of changing the landscape for NASH (or nonalcoholic steatohepatitis).
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account